Summit Healthcare Acquisition Corp. (the “Company”) is a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target under consideration or contemplation and the Company has not, nor has anyone on its behalf, contacted any prospective target business or had any discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although it intends to focus on healthcare.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
15-12G
Securities registration termination
16 Mar 23
8-K
Completion of Acquisition or Disposition of Assets
16 Mar 23
25-NSE
Exchange delisting
16 Mar 23
425
Business combination disclosure
14 Mar 23
8-K
Ys Biopharma and Summit Healthcare Announce
14 Mar 23
DEFA14A
Additional proxy soliciting materials
21 Feb 23
425
Business combination disclosure
21 Feb 23
8-K
Other Events
21 Feb 23
425
Business combination disclosure
8 Feb 23
DEFM14A
Proxy related to merger
8 Feb 23
Latest ownership filings
4
Bo Tan
21 Mar 23
4
Tao Bai
21 Mar 23
4
Thomas Folinsbee
21 Mar 23
4
Change in insider ownership
21 Mar 23
4
Cho Fai Poon
21 Mar 23
4
Ian Charles Stone
21 Mar 23
SC 13G
GLAZER CAPITAL, LLC
15 Feb 23
SC 13G/A
CANTOR FITZGERALD SECURITIES
15 Feb 23
SC 13G
ARISTEIA CAPITAL LLC
13 Feb 23
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
2 Feb 23
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 70.10 k | 70.10 k | 70.10 k | 70.10 k | 70.10 k | 70.10 k |
Cash burn (monthly) | 181.95 k | 83.75 k | 193.73 k | 127.32 k | 1.93 mm | 944.86 k |
Cash used (since last report) | 4.20 mm | 1.93 mm | 4.47 mm | 2.94 mm | 44.59 mm | 21.82 mm |
Cash remaining | -4.13 mm | -1.86 mm | -4.40 mm | -2.87 mm | -44.52 mm | -21.75 mm |
Runway (months of cash) | -22.7 | -22.3 | -22.7 | -22.5 | -23.1 | -23.0 |
Institutional ownership, Q1 2024
6.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 7.45 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Summit Healthcare Acquisition Sponsor | 5.30 mm | $0.00 |
Integrated Core Strategies | 1.13 mm | $0.00 |
Fitzgerald Securities Cantor | 1.03 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Mar 23 | Cho Fai Poon | Private Placement Warrants Class A Ordinary Shares | Sale back to company | Dispose D | Yes | No | 0 | 6,000,000 | 0.00 | 0 |
16 Mar 23 | Cho Fai Poon | Class B Ordinary Shares Class A Ordinary Shares | Sale back to company | Dispose D | Yes | No | 0 | 5,300,000 | 0.00 | 0 |
16 Mar 23 | Thomas Folinsbee | Class B Ordinary Shares Class A Ordinary Shares | Sale back to company | Dispose D | No | No | 0 | 25,000 | 0.00 | 0 |
16 Mar 23 | Bo Tan | Private Placement Warrants Class A Ordinary Shares | Sale back to company | Dispose D | Yes | No | 0 | 6,000,000 | 0.00 | 0 |
16 Mar 23 | Bo Tan | Class B Ordinary Shares Class A Ordinary Shares | Sale back to company | Dispose D | Yes | No | 0 | 5,300,000 | 0.00 | 0 |
16 Mar 23 | Tao Bai | Class B Ordinary Shares Class A Ordinary Shares | Sale back to company | Dispose D | No | No | 0 | 25,000 | 0.00 | 0 |
16 Mar 23 | Ian Charles Stone | Class B Ordinary Shares Class A Ordinary Shares | Sale back to company | Dispose D | No | No | 0 | 25,000 | 0.00 | 0 |